Pidilite Inds.Q2 FY25

Pidilite Inds. Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,464P/E: 58.4Market Cap: ₹1.5L CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Pidilite aims to maintain double-digit underlying volume growth, with a strong commitment to growth despite current market challenges.
  • Pioneer and growth categories are expanding faster than core categories, driving portfolio transformation from ~80% core to ~55% core and ~45% growth/pioneer.
  • Distribution expansion targets are set to improve numerical outlet coverage by 12-20% annually, with incremental increase in product assortment per outlet.
  • New pioneering products have a high success rate (~70-80%) and continuous piloting ensures relevant product launches.
  • The company plans to add at least 2 large new verticals annually with multiple subcategories, ensuring long-term category creation and growth.
  • Growth and demand will be driven by both new construction and repair/renovation markets, with approx. 70% demand from repair/renovation.
  • Improving rural incomes and government capital expenditure weighted to the second half provide optimism for better demand environment ahead.
  • Management remains confident about sustaining these growth trajectories through focused investments and market development initiatives.

See what Pidilite Inds. management said on margin guidance — free account, 30 seconds.

Fundraise plans

The document does not mention any current or future plans for fundraising through debt or equity. There is no indication of issuing new shares, raising equity capital, or taking on additional debt highlighted in the management discussion or Q&A sections. The focus in the discussions is on internal growth funding, investing in brand building, and expanding categories through existing resources and operational cash flows. Hence: - No mention of ongoing or planned debt or equity fundraising. - Emphasis on funding growth through internal cash flows and investments. - Current working capital and cash inflows remain healthy, supporting ongoing investments. - No indications of external capital raising in near future as per the document.

See what Pidilite Inds. management said on order book — free account, 30 seconds.

Capex plans

Yes
  • The company continues to invest significantly in growth, including a strong focus on pioneering new categories and products.
  • Over the last 2.5 years, 19 new facilities have been built, with ongoing investments in capacities that take time to ramp up.
  • There are clear investment criteria and separate allocations for core, growth, and pioneer categories, emphasizing sustained investment in building and expanding these areas.
  • Investments are right-sized for the brand and category-building, including longer-term pioneering efforts.
  • No specific new large capex announcements were made, but the company emphasizes patient, phased expansion and piloting before wide launches.
  • Future updates about expansions, like in smaller segments (paints, NBFC), will be shared after completing pilot phases by March.
  • The partnership with CollTech is progressing, including setting up an application center, indicating strategic investments toward new technology and markets.

Track Pidilite Inds. — get its next earnings analysis in your feed

How does Pidilite Inds. rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisPidilite Inds.
Rev 3Mar 3

How does Pidilite Inds. rank in Chemicals & Petrochemicals?

Compare Pidilite Inds. against every Chemicals & Petrochemicals company (Q2 FY25) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Prasol Chemicals Ltd (Q1 FY27)

    Q1 FY27 Revenue from Operations: ₹433.6 crores . Key investor presentation takeaways from Prasol Chemicals Ltd's Q1 FY27 investor presentation — and how it rank

  • Vipul Organics Ltd (Q4 FY26)

    Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated) . Key concall takeaways from Vipul Organics's Q4 FY26 earnings call — and how it ranks against…

  • Vipul Organics Ltd (Q1 FY27)

    Q1 FY27 net revenue: ₹51.78 crore, up +37.7% YoY (Page 13) . Key concall takeaways from Vipul Organics's Q1 FY27 earnings call — and how it ranks against…

  • Fine Organic Industries Ltd (Q1 FY27)

    Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key concall takeaways from Fine Organic…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →